Serum ferritin and cardiovascular disease: A 17-year follow-up study in Busselton, Western Australia

American Journal of Epidemiology

Volumn 158, Issue 2, 2003, Pages 144-149

  Knuiman, Matthew W ^a   Divitini, M L ^a   Olynyk, J K ^a   Cullen, D J ^b   Bartholomew, H C ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b FREMANTLE HOSPITAL   (Australia)

Author keywords

Cardiovascular diseases; Cohort studies; Ferritin; Proportional hazards models

Indexed keywords

FERRITIN;

CARDIOVASCULAR DISEASE;

ADULT; AGED; ARTICLE; AUSTRALIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HEALTH CARE COST; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; POPULATION RESEARCH; PROTEIN ANALYSIS; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; STROKE;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; WESTERN AUSTRALIA;

EID: 0037481178     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwg121     Document Type: Article

References (28)

1. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981;1:1293-4.
2. Sempos CT, Looker AC, Gillum RF. Iron and heart disease: the epidemiologic data. Nutr Rev 1996;54:73-84.
3. Meyers DG. The iron hypothesis - does iron cause atherosclerosis? Clin Cardiol 1996;19:925-9.
4. Salonen JT, Nyyssonen K, Korpela H, et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-11.
5. Sempos CT. Do body iron stores increase the risk of developing coronary heart disease? Am J Clin Nutr 2002;76:501-3.
6. Ma J, Stampfer MJ. Body iron stores and coronary heart disease. Clin Chem 2002;48:601-3.
7. Cook JD, Lipschitz DA, Miles LE, et al. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr 1974;27:681-7.
8. Kiechl S, Willeit J, Egger G, et al. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 1997;96:3300-7.
9. Sullivan JL. Iron versus cholesterol - perspectives on the iron and heart disease debate. J Clin Epidemiol 1996;49:1345-52.
10. De Valk B, Marx JJM. Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med 1999;159:1542-8.
11. Fox CJ, Cullen DJ, Knuiman MW, et al. Effects of body iron stores and haemochromatosis genotypes on coronary heart disease outcomes in the Busselton health study. J Cardiovasc Risk 2002;9:287-93.
12. Knuiman MW, Cullen KJ, Bulsara MK, et al. Mortality trends, 1965 to 1989, in Busselton, the site of repeated health surveys and interventions. Aust J Public Health 1994;18:129-35.
13. Knuiman MW, Jamrozik K, Welborn TA, et al. Age and secular trends in risk factors for cardiovascular disease in Busselton. Aust J Public Health 1995;19:375-82.
14. Welborn TA, Cumpston GN, Cullen KJ, et al. The prevalence of coronary heart disease and associated factors in an Australian rural community. Am J Epidemiol 1969;89:521-36.
15. Holman CDJ, Bass AJ, Rouse IL, et al. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health 1999;23:453-9.
16. Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 1986;73:1-11.
17. Wacholder S, Gail M, Pee D. Selecting an efficient design for assessing exposure-disease relationships in an assembled cohort. Biometrics 1991;47:63-76.
18. Barlow WE. Robust variance estimation for the case-cohort design. Biometrics 1994;50:1064-72.
19. SAS Institute, Inc. Statistical analysis system, version 6.12. Cary NC: SAS Institute, Inc, 1997.
20. Ichikawa L, Barlow W. ROBPHREG, version 1.0.2: survival analysis macro with robust variance. Seattle, WA: Center for Health Studies, Group Health Cooperative, 1998. (http://lib.stat.cmu.edu/general/robphreg).
21. Jamrozik K, Hockey R. Trends in risk factors for vascular diseases in Australia. Med J Aust 1989;150:14-18.
22. Klipstein-Grobusch K, Koster JF, Grobbee DE, et al. Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr 1999;69:1231-6.
23. Tuomainen TP, Punnonen K, Nyyssonen K, et al. Association between body iron stores and risk of myocardial infarction in men. Circulation 1998;97:1461-6.
24. Salonen JT, Nyyssonen K, Salonen R. Body iron stores and the risk of coronary heart disease. (Letter). N Engl J Med 1994;331:1159.
25. Sempos CT, Looker AC, Gillum RE, et al. Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study. Ann Epidemiol 2000;10:441-8.
26. Salonen JT, Tuomainen TP, Salonen R, et al. Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Epidemiol 1998;148:445-51.
27. Meyers DG, Strickland D, Maloney PA, et al. Possible association of a reduction in cardiovascular events with blood donation. Heart 1997;78:188-93.
28. Ascherio A, Rimm EB, Giovannucci W, et al. Blood donations and risk of coronary heart disease in men. Circulation 2001;103:52-7.